Linarin Protects Against CCl4-Induced Acute Liver Injury via Activating Autophagy and Inhibiting the Inflammatory Response: Involving the TLR4/MAPK/Nrf2 Pathway
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s433591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Lulu Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Linarin has been implicated in the inhibition of inflammatory responses and hepatoprotective effects. However, the precise mechanism by which Linarin integrates injury-induced signaling from inflammatory responses and oxidative stress remains unclear.
Methods
We evaluated the role of Linarin in a mouse model of carbon tetrachloride (CCl4)-induced acute liver injury. Mice were orally pretreated with Linarin or vehicle for seven consecutive days, followed by intraperitoneal injection with 0.2% (v/v) CCl4. To investigate the mechanism of action on oxidative stress, CCl4-stimulated HepG2 cells were utilized.
Results
Our results revealed Linarin remarkably attenuated the loss of hepatic architecture, inflammatory cell infiltration, serum transaminases, and pro-inflammatory cytokines induced by CCl4. Linarin attenuated CCl4-induced oxidative stress by increasing the expression of cytosolic Nrf2 (nuclear factor erythroid 2-related factor 2), inducing nuclear localization of Nrf2, and increasing stress-induced protein heme oxygenase-1 (HO-1). Additionally, Linarin decreased the expression of toll-like receptors (TLR)-4, and its downstream proteins, MyD88, IRAK1, and TRAF6. Furthermore, Linarin reversed CCl4-induced phosphorylation of ERK, p38, and JNK. Importantly, Linarin increased the expression of both LC3II and Beclin 1, which are hallmarks of autophagic flux. Autophagy-mediated hepatoprotective effects in Linarin-treated HepG2 cells were mitigated by the autophagy inhibitor 3-MA. However, combined treatment of Linarin with 3-MA failed to significantly reverse cell apoptosis and the production of transaminases and pro-inflammatory cytokines.
Conclusion
Linarin prevents acute liver injury, possibly by alleviating ROS-induced oxidative stress, inhibiting TLR4/MyD88 and JNK/p38/ERK-mediated inflammatory responses, and promoting Beclin 1/LC3II-mediated autophagic flux.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
- Department of Pharmacy, Wuhan NO.1 Hospital, Wuhan, Hubei, People's Republic of China.
- Department of Pharmacy, Huangshi Central Hospital, Huangshi, Hubei, People's Republic of China.
Zitieren
APA
Li, L., Lan, Y., Wang, F., & Gao, T. (2023). Linarin Protects Against CCl4-Induced Acute Liver Injury via Activating Autophagy and Inhibiting the Inflammatory Response: Involving the TLR4/MAPK/Nrf2 Pathway. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s433591
Vancouver
Li L, Lan Y, Wang F, Gao T. Linarin Protects Against CCl4-Induced Acute Liver Injury via Activating Autophagy and Inhibiting the Inflammatory Response: Involving the TLR4/MAPK/Nrf2 Pathway. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s433591
BibTeX
@article{Li2023,
author = {Li, Lulu and Lan, Yan and Wang, Fuqian and Gao, Tiexiang},
title = {Linarin Protects Against CCl4-Induced Acute Liver Injury via Activating Autophagy and Inhibiting the Inflammatory Response: Involving the TLR4/MAPK/Nrf2 Pathway},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s433591}
}
EUVIMED